Why Intersect ENT Is Down Big Today

Shares of Intersect ENT (NASDAQ: XENT), a medical device company focused on products that treat ear, nose, and throat problems, are down 17% as of 2:10 p.m. EDT on Friday. The huge drop is attributable to disappointing quarterly results.

Here are Intersect ENT's headline numbers from the quarter:

The worse-than-expected quarterly results were bad enough, but management poured salt on the wound by cutting guidance, too:

Continue reading

Quelle Fool.com